The first stop for professional medicines advice

Intrathecal medicines

29 results

RelevanceNewest firstOldest firstTitle
Applied filters

Ziconotide: informing intrathecal risk assessment

11 August 2022Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Vancomycin: informing intrathecal risk assessment

11 August 2022Vancomycin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Trastuzumab: informing intrathecal risk assessment

11 August 2022Trastuzumab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Topotecan: informing intrathecal risk assessment

11 August 2022Topotecan products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Thiotepa: informing intrathecal risk assessment

11 August 2022Thiotepa products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Ropivacaine: informing intrathecal risk assessment

11 August 2022Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Rituximab: informing intrathecal risk assessment

11 August 2022Rituximab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Phenol: informing intrathecal risk assessment

11 August 2022Phenol products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Pharmacy Intrathecal Chemotherapy Audit Aide Memoire 4th Edition (Yellow Cover)

24 May 2010This audit document is intended to be used to audit Pharmacy aspects of the safe administration of intrathecal chemotherapy, as part of the EL(97)52 Audit…

Omnipaque: informing intrathecal risk assessment

11 August 2022Omnipaque products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration